Clinical Trial Update: Prevention of Severe Acute Graft-versus-host Disease in Adult Patients Using a daGOAT Model [Phase 2]

View source ↗

Summary

Phase 2 trial completed evaluating a daGOAT model for preventing severe acute graft-versus-host disease in adult transplant patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Transplant-Related Disorder | Phase 2 | Status: COMPLETED